Waters Corporation
Financials
Valuation Metrics
Waters Corporation's Market Cap is $36.81B. At end of 2025 it was $22.62B. Ranked #402 of 3,111 in US market (top 13%), #286 of 1,666 on NYSE (top 17%), #23 of 206 in Health Care Equipment & Services (top 11%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $36.81B | US#402/3,111 Sec#23/206 |
| Revenue | $3.77B | US#1,087/3,111 Sec#61/206 |
| Net Income | $449M | US#870/3,111 Sec#46/206 |
| Total Assets | $24.53B | US#547/3,111 Sec#26/206 |
| Net Assets | $15.29B | US#302/3,111 Sec#18/206 |
| Employees | 7,900 | US#677/3,111 Sec#61/206 |
| Value | ||
| P/E | 81.93x | US#2,020/3,111 Sec#102/206 |
| P/B | 2.41x | US#1,447/3,111 Sec#79/206 |
| P/S | 9.76x | US#2,654/3,111 Sec#186/206 |
| EV/EBITDA | 45.34x | US#2,330/3,111 Sec#122/206 |
| FCF Yield | 0.72% | US#2,170/3,111 Sec#134/206 |
| Profitability | ||
| ROE | 2.94% | US#1,993/3,111 Sec#95/206 |
| ROA | 1.83% | US#1,663/3,111 Sec#97/206 |
| Op. Margin | 17.08% | US#1,105/3,111 Sec#38/206 |
| Revenue Growth | 91.48% | US#165/3,111 Sec#5/206 |
| Earnings Growth | -159.32% | US#2,183/3,111 Sec#112/206 |
| Financial Health | ||
| Debt Ratio | 60.42% | US#680/3,111 Sec#80/206 |
| Total Debt | $5.57B | US#619/3,111 Sec#30/206 |
| FCF | $264M | US#1,211/3,111 Sec#69/206 |
| Cash | $462M | US#1,121/3,111 Sec#66/206 |
| Current Ratio | 1.79x | US#1,399/3,111 Sec#124/206 |
| Net Debt/EBITDA | 5.53x | US#2,113/3,111 Sec#129/206 |
| Performance | ||
| 1Y Return | 29.13% | US#1,150/3,111 Sec#74/206 |
| 1M Return | -1.16% | US#1,577/3,111 Sec#115/206 |
| From 52W High | -9.48% | US#889/3,111 Sec#53/206 |
| 1Y MDD | -31.32% | US#1,477/3,111 Sec#58/206 |
| Trading | ||
| Volume | 980,958 shares | US#1,938/3,111 Sec#125/206 |
| Trading Value | $369M | US#490/3,111 Sec#38/206 |
| Per Share | ||
| EPS | $10.79 | US#211/3,111 Sec#14/206 |
| BPS | $43.01 | US#528/3,111 Sec#37/206 |
Company Info
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.